These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7519223)

  • 21. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
    Livingston BD; Crimi C; Grey H; Ishioka G; Chisari FV; Fikes J; Grey H; Chesnut RW; Sette A
    J Immunol; 1997 Aug; 159(3):1383-92. PubMed ID: 9233635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help.
    Fayolle C; Abdel-Motal UM; Berg L; Deriaud E; Jondal M; Leclerc C
    Immunology; 1996 Sep; 89(1):41-5. PubMed ID: 8911138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study.
    Le Gal FA; Prevost-Blondel A; Lengagne R; Bossus M; Farace F; Chaboissier A; Gras-Masse H; Engelhard VH; Guillet JG; Gahéry-Ségard H
    Int J Cancer; 2002 Mar; 98(2):221-7. PubMed ID: 11857412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
    Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
    Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.
    Fraser DG; Leib SR; Zhang BS; Mealey RH; Brown WC; McGuire TC
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):983-93. PubMed ID: 16085917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The optimization of helper T lymphocyte (HTL) function in vaccine development.
    Alexander J; Fikes J; Hoffman S; Franke E; Sacci J; Appella E; Chisari FV; Guidotti LG; Chesnut RW; Livingston B; Sette A
    Immunol Res; 1998; 18(2):79-92. PubMed ID: 9844827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.
    Sauzet JP; Gras-Masse H; Guillet JG; Gomard E
    Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
    Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF
    Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response.
    Wiesmüller KH; Bessler WG; Jung G
    Int J Pept Protein Res; 1992; 40(3-4):255-60. PubMed ID: 1282504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a noncovalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response.
    Nehete PN; Arlinghaus RB; Sastry KJ
    Viral Immunol; 1994; 7(4):189-97. PubMed ID: 7576033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCR-ABL-specific CD4
    Ueda N; Zhang R; Tatsumi M; Liu TY; Kitayama S; Yasui Y; Sugai S; Iwama T; Senju S; Okada S; Nakatsura T; Kuzushima K; Kiyoi H; Naoe T; Kaneko S; Uemura Y
    Cell Mol Immunol; 2018 Jan; 15(1):15-26. PubMed ID: 27181332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of T cell accessory molecules in the generation of class II-specific xenogeneic cytolytic T cells.
    Greenstein JL; Foran JA; Gorga JC; Burakoff SJ
    J Immunol; 1986 Apr; 136(7):2358-63. PubMed ID: 2419431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.
    Gao XM; Liew FY; Tite JP
    J Immunol; 1989 Nov; 143(9):3007-14. PubMed ID: 2478631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors.
    Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ
    J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
    Blazevic V; Ranki A; Krohn KJ
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
    Ciavarra RP
    Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.